Editas Medicine, Inc.
EDIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$53 | -$76 | -$45 |
| Dep. & Amort. | $1 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $3 | $3 | $4 |
| Change in WC | -$11 | -$5 | $18 | -$12 |
| Other Non-Cash | $2 | $3 | $6 | $1 |
| Operating Cash Flow | -$31 | -$50 | -$48 | -$51 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $40 | $42 | $57 | $31 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $40 | $43 | $56 | $31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3 | $0 | $0 |
| Stock Issued | $17 | $7 | $1 | $56 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $3 | -$3 | $0 |
| Financing Cash Flow | $17 | $7 | -$1 | $56 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $26 | -$0 | $7 | $36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142 | $143 | $135 | $100 |
| End Cash | $168 | $142 | $143 | $135 |
| Free Cash Flow | -$31 | -$50 | -$48 | -$51 |